首页 | 本学科首页   官方微博 | 高级检索  
检索        

西地那非联合贝前列素治疗先天性心脏病并肺动脉高压的疗效观察
引用本文:梁新亮,卢厚新,刘煜昊,张传军.西地那非联合贝前列素治疗先天性心脏病并肺动脉高压的疗效观察[J].中国药房,2011(34):3213-3215.
作者姓名:梁新亮  卢厚新  刘煜昊  张传军
作者单位:河南省人民医院;
基金项目:河南省科技厅2011年重点科技攻关项目(112102310071)
摘    要:目的:观察西地那非联合贝前列素治疗先天性心脏病并肺动脉高压的疗效及安全性。方法:将62例符合条件的患者随机分成A、B、C组,分别给予西地那非、贝前列素、西地那非联合贝前列素,每组服药时间均为6个月。观察3组用药前、后6 min步行距离(6MWD)、平均肺动脉压(mPAP)及肺血管阻力(PVR)等指标变化,记录用药期间的不良反应。结果:C组6MWD增加较A、B组明显(P<0.05);A、C组mPAP、PVR较用药前明显下降(P<0.05),且C组下降更明显(P<0.05),B组变化不明显。各组间不良反应无明显差异,均未见严重不良反应。结论:西地那非联合贝前列素治疗先天性心脏病并肺动脉高压较2药单用更有效,且安全,值得推荐。

关 键 词:肺动脉高压  西地那非  贝前列素  先天性心脏病

Efficacy Observation of Sildenafil Combined with Beraprost in the Treatment of Congenital Heart Disease Complicating with Pulmonary Artery Hypertension
LIANG Xin-liang,LU Hou-xin,LIU Yu-hao,ZHANG Chuan-jun.Efficacy Observation of Sildenafil Combined with Beraprost in the Treatment of Congenital Heart Disease Complicating with Pulmonary Artery Hypertension[J].China Pharmacy,2011(34):3213-3215.
Authors:LIANG Xin-liang  LU Hou-xin  LIU Yu-hao  ZHANG Chuan-jun
Institution:(He' nan Provincial People' s Hospital, Zhengzhou 450003, China)
Abstract:OBJECTIVE:To observe the therapeutic efficacy and safety of sildenafil combined with beraprost in the treatment of congenital heart disease complicating with pulmonary artery hypertension. METHODS:62 eligible patients were randomly divided into group A, B, C. They were given sildenafil, beraprost , combined therapy of sildenafil and beraprost respectively for 6 months. The changes of 6MWD, mPAP and PVR in 3 groups were observed before and after administration, and adverse drug reactions were recorded. RESUL...
Keywords:Pulmonary artery hypertension  Sildenafil  Beraprost  Congenital heart disease  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号